Skip to content

For in vitro research use only. Not for human or animal consumption.

VaultLabs logo

Peptide encyclopedia · Growth hormone secretagogue research

Ipamorelin research summary

Growth hormone secretagogue peptide (GHRP-class) · Full compound profile

Also see the expanded Ipamorelin compound database page with filters, related articles, and catalog links.

All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.

Ipamorelin is a synthetic pentapeptide that acts as a selective agonist at the growth hormone secretagogue receptor (GHS-R1a), the same receptor targeted by the endogenous hormone ghrelin. Its defining characteristic in the literature is selectivity relative to earlier secretagogues. VaultLabs supplies ipamorelin as a reference material for in vitro laboratory research only. In the VaultLabs catalogue this is Growth hormone secretagogue peptide (GHRP-class) material for in vitro laboratory research, not a medicine and not a protocol.

What it is
Growth hormone secretagogue peptide (GHRP-class)
Category
Growth hormone secretagogue research
CAS
Not printed on the monograph
Catalogue
5 mg lyophilized, 5 mg + 5 mg lyophilized
Catalogue price before VAT
5 mg at AED 299; 5 mg + 5 mg at AED 399

Identity on this record

Chemical name: Ipamorelin.

Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2.

Receptor target: Growth hormone secretagogue receptor (GHS-R1a).

Structural class: Synthetic pentapeptide with non-standard residues.

Appearance: White lyophilised powder.

Catalog availability: Standalone 5 mg vial; also a component of the CJC-1295 / Ipamorelin dual kit.

Those identifiers describe Ipamorelin as a substance. They do not describe a particular vial. The vial is identified by the name, the nominal fill, and the lot number on its label, checked against the published certificate.

What the catalogue actually sells

Ipamorelin 5mg is the 5 mg lyophilized unit, listed at AED 299 before VAT. The product record stores that sealed unit at 2–8 °C · protect from light. CJC-1295 (no DAC) 5mg + Ipamorelin 5mg is the 5 mg + 5 mg lyophilized unit, listed at AED 399 before VAT. The product record stores that sealed unit at 2–8 °C.

Prices are merchandise prices in AED, exclusive of VAT. VAT is added at checkout. A price on this summary is the figure on the product record for Ipamorelin, not a delivered-cost quote.

Lots and certificates

Lot 238930 for CJC-1295 (no DAC) 5mg + Ipamorelin 5mg is a Janoshik Analytical report. The published record states Content reported. Figures printed on the report: Ipamorelin 4.83 mg; CJC-1295 (mod GRF 1-29) 4.68 mg. Method line on that report: CJC No DAC - MOD GRF (1-29)/Ipamorelin blend analysis. The laboratory file is linked from the certificate page. Open CJC-1295 (no DAC) 5mg + Ipamorelin 5mg certificate or match lot 238930 in batch verification. That report qualifies this lot only.

Lot VL-CJCIPA-20260321 is the catalogue certificate for CJC-1295 (no DAC) 5mg + Ipamorelin 5mg. Read it on CJC-1295 (no DAC) 5mg + Ipamorelin 5mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.

Lot VL-IPA-20260917 is the catalogue certificate for Ipamorelin 5mg. Read it on Ipamorelin 5mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.

Ipamorelin has both a laboratory report and catalogue certificates. Janoshik Analytical lot 238930 is the third-party file. The other lot numbers are catalogue certificates for their own fills. Match the printed lot. Do not treat one purity line as the result for every vial.

How the compound record describes the literature

Developed by Novo Nordisk in the 1990s as a selective secretagogue candidate. Research supply demand reflects secretagogue model literature rather than clinical applications.

Topics named on the Ipamorelin record, as literature context rather than as outcomes VaultLabs claims: Pituitary somatotroph assays; Selective GH release comparisons; Combination studies with GHRH analogs; Receptor binding characterization.

That is context for identifying Ipamorelin. It is not a claim that a vial produces a result in a person, an animal, or a study VaultLabs has not published. VaultLabs does not provide dosage, administration, study-design, or medical guidance.

Points the monograph already states

Points already written on the Ipamorelin monograph, so a reader can check them against that page:

A five-residue synthetic peptide: Aib-His-D-2-Nal-D-Phe-Lys-NH2, containing non-standard and D-configured amino acids.

Acts at the ghrelin receptor GHS-R1a — a different target from GHRH analogues such as CJC-1295.

Described in the literature as more selective than earlier growth hormone secretagogues, which is the basis of most research interest in it.

The unnatural residues make it resistant to standard proteolysis but also mean generic peptide assumptions do not always apply.

Prohibited in sport under the World Anti-Doping Agency list; not an approved medicine in any jurisdiction.

Dispatch and the research-use boundary

VaultLabs dispatches Ipamorelin from Dubai. Orders leave fulfillment within 24 hours, 7 days a week. Standard delivery is AED 35 to every emirate, and delivery is free when the post-discount merchandise subtotal is AED 500 or more. Checkout shows the fee for the address entered. All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use. VaultLabs does not provide dosage, administration, study-design, or medical guidance.

The full narrative record is the Ipamorelin compound monograph. Handling of the sealed unit is the Ipamorelin storage guide. Questions are collected on the Ipamorelin FAQ. How it differs from neighbouring records is the Ipamorelin comparison.

Questions this page answers

What is Ipamorelin on this site?

Ipamorelin is a synthetic pentapeptide that acts as a selective agonist at the growth hormone secretagogue receptor (GHS-R1a), the same receptor targeted by the endogenous hormone ghrelin. Its defining characteristic in the literature is selectivity relative to earlier secretagogues. VaultLabs supplies ipamorelin as a reference material for in vitro laboratory research only. VaultLabs supplies it as in vitro research material. The monograph does not print a CAS number for this entry.

Related compounds

Research tools

Catalog products

Next recommended reading

All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.